InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on InMode, with a price target of $21.00. According to TipRanks, Miksic is a 4-star analyst with an average return of 4.6% ...
Total Revenue (Q4 2025): $103.9 million, up from $97.9 million in Q4 2024. Total Revenue (Full Year 2025): $370.5 million, a 6% decrease compared to 2024. International Sales (Q4 2025): $48.5 million, ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...
InMode said Q4 came in “slightly better than expected” but full-year revenue fell about 6% to $370.5M, and management expects 2026 to be a stabilization year rather than a return to growth despite ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. If you are looking at InMode and wondering whether the current share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results